Abstract
Point-of-care testing for cardiac injury markers has unique attributes affording favorable comparison with performance of the clinical laboratory. Numerous studies have confirmed the accuracy, rapidity, and potential cost savings of this readily applicable bedside method that favor its use for early identification of both high-risk patients with ACS and low-risk patients with chest pain who are suitable for early discharge. The economic impact of point-of-care testing requires consideration of its effect on the overall cost of patient care.
| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 22-27 |
| Number of pages | 6 |
| Journal | SENDROM |
| Volume | 18 |
| Issue number | 9 |
| State | Published - Sep 2006 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Kardiyak belirteçlerin hasta başi deǧerlendirmesi. / Amsterdam, Ezra A; Deedwania, Prakash.
In: SENDROM, Vol. 18, No. 9, 09.2006, p. 22-27.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Kardiyak belirteçlerin hasta başi deǧerlendirmesi
AU - Amsterdam, Ezra A
AU - Deedwania, Prakash
PY - 2006/9
Y1 - 2006/9
N2 - Point-of-care testing for cardiac injury markers has unique attributes affording favorable comparison with performance of the clinical laboratory. Numerous studies have confirmed the accuracy, rapidity, and potential cost savings of this readily applicable bedside method that favor its use for early identification of both high-risk patients with ACS and low-risk patients with chest pain who are suitable for early discharge. The economic impact of point-of-care testing requires consideration of its effect on the overall cost of patient care.
AB - Point-of-care testing for cardiac injury markers has unique attributes affording favorable comparison with performance of the clinical laboratory. Numerous studies have confirmed the accuracy, rapidity, and potential cost savings of this readily applicable bedside method that favor its use for early identification of both high-risk patients with ACS and low-risk patients with chest pain who are suitable for early discharge. The economic impact of point-of-care testing requires consideration of its effect on the overall cost of patient care.
UR - http://www.scopus.com/inward/record.url?scp=33750942118&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750942118&partnerID=8YFLogxK
M3 - Article
VL - 18
SP - 22
EP - 27
JO - SENDROM
JF - SENDROM
SN - 1016-5134
IS - 9
ER -